CHRM3 and renal cell carcinoma: Molecular docking findings indicate that the environmental endocrine-disrupting chemical BPA specifically interacts with key targets essential for the function of renal cell carcinoma cells, including CHRM3, GABBR1, CCR4, KCNN4, PRKCE, CYP2C9, HPGD, and FASN.